Details

Updated guidance on respiratory syncytial virus (RSV) vaccines for older adults including the expanded use of RSVPreF3 for individuals 50-59 years of age and use of the new mRNA-1345 vaccine - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 18, 2025 · edition #1
Timestamp: 2025-04-18T14:13:04.631Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-statement-updated-guidance-rsv-vaccines-older-adults-including-expanded-use-rsvpref3-individuals-50-59-years-age-use-new-mrna-1345-vaccine.html?wbdisable=true
Replay URL: https://replay.healtharchive.ca/job-1/20250418141304/https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-statement-updated-guidance-rsv-vaccines-older-adults-including-expanded-use-rsvpref3-individuals-50-59-years-age-use-new-mrna-1345-vaccine.html?wbdisable=true#ha_snapshot=140442
ID: 140442
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots